Arkadios Wealth Advisors Has $1.05 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Arkadios Wealth Advisors increased its holdings in shares of Danaher Co. (NYSE:DHRGet Rating) by 2.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,155 shares of the conglomerate’s stock after buying an additional 115 shares during the period. Arkadios Wealth Advisors’ holdings in Danaher were worth $1,053,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. GHP Investment Advisors Inc. acquired a new stake in Danaher during the 1st quarter worth approximately $26,000. Lloyd Advisory Services LLC. acquired a new position in shares of Danaher in the 1st quarter worth approximately $26,000. Landmark Wealth Management LLC acquired a new position in shares of Danaher in the 1st quarter worth approximately $32,000. Lansing Street Advisors acquired a new position in shares of Danaher in the 1st quarter worth approximately $34,000. Finally, American National Bank acquired a new position in shares of Danaher in the 1st quarter worth approximately $35,000. 77.27% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent analyst reports. Credit Suisse Group initiated coverage on shares of Danaher in a research report on Wednesday, August 24th. They issued an “outperform” rating and a $340.00 price target on the stock. Evercore ISI dropped their price target on shares of Danaher from $320.00 to $280.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 5th. Sanford C. Bernstein began coverage on shares of Danaher in a research report on Tuesday, August 16th. They issued an “outperform” rating and a $340.00 price target on the stock. Robert W. Baird lifted their price objective on shares of Danaher from $319.00 to $325.00 in a research note on Friday, July 22nd. Finally, Benchmark lowered their price objective on shares of Danaher from $345.00 to $325.00 and set a “buy” rating for the company in a research note on Tuesday. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Danaher presently has an average rating of “Buy” and an average price target of $321.75.

Insider Transactions at Danaher

In other news, CEO Rainer Blair sold 25,000 shares of the company’s stock in a transaction on Monday, August 15th. The shares were sold at an average price of $300.00, for a total value of $7,500,000.00. Following the completion of the sale, the chief executive officer now owns 79,739 shares in the company, valued at approximately $23,921,700. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CEO Rainer Blair sold 25,000 shares of the business’s stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $300.00, for a total value of $7,500,000.00. Following the transaction, the chief executive officer now directly owns 79,739 shares of the company’s stock, valued at approximately $23,921,700. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Joakim Weidemanis sold 12,000 shares of the business’s stock in a transaction dated Monday, July 25th. The stock was sold at an average price of $271.13, for a total transaction of $3,253,560.00. Following the completion of the transaction, the executive vice president now directly owns 74,398 shares in the company, valued at $20,171,529.74. The disclosure for this sale can be found here. Insiders sold a total of 40,906 shares of company stock worth $11,823,179 in the last quarter. 11.20% of the stock is currently owned by corporate insiders.

Danaher Stock Performance

Shares of DHR stock opened at $266.43 on Friday. The firm has a market capitalization of $193.81 billion, a PE ratio of 31.38, a price-to-earnings-growth ratio of 1.29 and a beta of 0.88. The firm has a fifty day simple moving average of $280.99 and a two-hundred day simple moving average of $269.91. The company has a current ratio of 1.75, a quick ratio of 1.32 and a debt-to-equity ratio of 0.45. Danaher Co. has a 12 month low of $233.71 and a 12 month high of $331.68.

Danaher (NYSE:DHRGet Rating) last announced its quarterly earnings results on Thursday, July 21st. The conglomerate reported $2.76 EPS for the quarter, beating analysts’ consensus estimates of $2.35 by $0.41. Danaher had a net margin of 20.61% and a return on equity of 18.57%. The business had revenue of $7.75 billion during the quarter, compared to analyst estimates of $7.29 billion. During the same quarter in the previous year, the business posted $2.46 EPS. Danaher’s quarterly revenue was up 7.4% on a year-over-year basis. Analysts forecast that Danaher Co. will post 10.4 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be paid a $0.25 dividend. The ex-dividend date is Thursday, September 29th. This represents a $1.00 annualized dividend and a dividend yield of 0.38%. Danaher’s payout ratio is 11.78%.

Danaher Profile

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

See Also

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.